One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papershttps://doi.org/10.1182/blood.v130.suppl_1.577.577
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
 Citations: 6 |
Affiliation: Academic Medical Center, University of Milan, Novartis (Switzerland), The Ohio State University, James Cancer Hospital, Emory University, Juravinski Hospital, McMaster University, Hôpital Maisonneuve-Rosemont, Université de Montréal, The University of Texas MD Anderson Cancer Center, Peter MacCallum Cancer Centre, Medical University of Vienna, University of Michigan–Ann Arbor, Michigan Center for Translational Pathology, Tris Pharma (United States), UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Oregon Health & Science University, Tokyo National Hospital, Oslo University Hospital, NewYork–Presbyterian Hospital, New York Hospital Queens, Presbyterian Hospital, Hokkaido University, University Hospital Cologne, University of Minnesota, University of Chicago, University of Sydney, Hospices Civils de Lyon, University of Würzburg, University of Pennsylvania, UPMC Hillman Cancer Center, University of Kansas Medical CenterPrimary Analysis of Juliet: A Global, Pivotal, Phase 2 Trial of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
